tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

LENZ Stock Latest News

Lenz Therapeutics files to sell 13.07M shares of common stock for holders
The FlyLenz Therapeutics files to sell 13.07M shares of common stock for holders
2d ago
LENZ
Lenz Therapeutics files $500M mixed securities shelf
PremiumThe Fly
Lenz Therapeutics files $500M mixed securities shelf
2d ago
LENZ
Lenz Therapeutics’ Earnings Call Highlights Positive Outlook
PremiumCompany Announcements
Lenz Therapeutics’ Earnings Call Highlights Positive Outlook
15d ago
LENZ
Promising Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid Strong Market Position and Upcoming Product Launch
PremiumRatings
Promising Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid Strong Market Position and Upcoming Product Launch
16d ago
LENZ
Lenz Therapeutics price target raised to $38 from $37 at BofA
PremiumThe Fly
Lenz Therapeutics price target raised to $38 from $37 at BofA
17d ago
LENZ
LENZ Therapeutics: Innovative Presbyopia Treatment and Strategic Growth Reinforce Buy Rating
PremiumRatingsLENZ Therapeutics: Innovative Presbyopia Treatment and Strategic Growth Reinforce Buy Rating
17d ago
LENZ
Promising Outlook for LENZ Therapeutics: Buy Rating Backed by Strategic Marketing and Anticipated FDA Approval
Premium
Ratings
Promising Outlook for LENZ Therapeutics: Buy Rating Backed by Strategic Marketing and Anticipated FDA Approval
17d ago
LENZ
Lenz Therapeutics price target raised to $47 from $44 at Citi
Premium
The Fly
Lenz Therapeutics price target raised to $47 from $44 at Citi
17d ago
LENZ
Promising Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid FDA Progress and Commercial Readiness
PremiumRatings
Promising Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid FDA Progress and Commercial Readiness
17d ago
LENZ
Buy Rating for LENZ Therapeutics Driven by Promising LNZ100 Eye Drop Prospects
PremiumRatings
Buy Rating for LENZ Therapeutics Driven by Promising LNZ100 Eye Drop Prospects
17d ago
LENZ
Lenz Therapeutics reports Q4 EPS (46c), consensus (40c)
PremiumThe Fly
Lenz Therapeutics reports Q4 EPS (46c), consensus (40c)
18d ago
LENZ
Closing Bell Movers: Harrow spikes 24% on revenue beat, leverage update
PremiumThe Fly
Closing Bell Movers: Harrow spikes 24% on revenue beat, leverage update
19d ago
NGS
BKKT
Lenz Therapeutics initiated with a Buy at TD Cowen
PremiumThe FlyLenz Therapeutics initiated with a Buy at TD Cowen
20d ago
LENZ
Buy Rating for LENZ Therapeutics Driven by Promising LNZ100 Efficacy and Market Potential
Premium
Ratings
Buy Rating for LENZ Therapeutics Driven by Promising LNZ100 Efficacy and Market Potential
20d ago
LENZ
Patent Challenges Threaten Lenz Therapeutics’ Market Strategy and Financial Stability
Premium
Company Announcements
Patent Challenges Threaten Lenz Therapeutics’ Market Strategy and Financial Stability
5M ago
LENZ
Lenz Therapeutics price target raised to $36 from $32 at Leerink
PremiumThe Fly
Lenz Therapeutics price target raised to $36 from $32 at Leerink
5M ago
LENZ
Lenz Therapeutics reports Q3 EPS (38c), consensus (46c)
PremiumThe Fly
Lenz Therapeutics reports Q3 EPS (38c), consensus (46c)
5M ago
LENZ
Lenz Therapeutics, Corxel Pharmaceuticals report topline data from JX07001 trial
PremiumThe Fly
Lenz Therapeutics, Corxel Pharmaceuticals report topline data from JX07001 trial
5M ago
LENZ
One new option listing and ten option delistings on October 21st
PremiumThe Fly
One new option listing and ten option delistings on October 21st
6M ago
AFIB
BHRB
Lenz Therapeutics announces FDA acceptance of NDA for LNZ100
PremiumThe FlyLenz Therapeutics announces FDA acceptance of NDA for LNZ100
6M ago
LENZ
William Blair biotech analysts hold an analyst/industry conference call
Premium
The Fly
William Blair biotech analysts hold an analyst/industry conference call
6M ago
LENZ
Lenz Therapeutics initiated with an Outperform at Raymond James
Premium
The Fly
Lenz Therapeutics initiated with an Outperform at Raymond James
6M ago
LENZ

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >